The effects of isoflavone supplementation in the treatment of non atypical endometrial hyperplasia
Phase 3
- Conditions
- on atypical endometrial hyperplasia.Endometrial hyperplasiaN85.0
- Registration Number
- IRCT20200531047614N3
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Women aged 30 to 45 years who are diagnosed with non atypical endometrial hyperplasia
Exclusion Criteria
Those taking any hormonal medicine within 6 months prior to enrollment in the study
Patients with focal endometrial lesions
atypical endometrial hyperplasia
Women with congenital uterine anomalies
Menopause women
Hypersensitivity to soybean products.
Unwillingness to cooperate.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endometrial histology. Timepoint: At the beginning of the study and after 3 months of intervention. Method of measurement: Biopsy.
- Secondary Outcome Measures
Name Time Method Serum estradiol levels. Timepoint: At the beginning of the study and after 3 months of intervention. Method of measurement: Elisa.;Drug side-effects. Timepoint: At the beginning of the study and after 3 months of intervention. Method of measurement: questionnaire.